Fundraising Fox
/Companies
Sign in

BioRegenx

OTC: BRGX

Chattanooga, US · Founded 2021 · Nevada corporation

Find your way into BioRegenx

3 people in our graph can introduce you to the BioRegenx team.

Sign up to see every warm intro you have to BioRegenx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BioRegenx team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

BioRegenx develops hardware and software for microscopy imaging of the endothelial glycocalyx, along with microvascular regenerative products, serving doctors, research scientists, and wellness consumers. The company combines diagnostic imaging technology with regenerative therapeutics in the medical device and wellness sector.

AI & Machine LearningBiotechHealthtechLongevityMedical Devices

Founders & leadership

HVHans Vink
Hans VinkExecutive
WRWilliam Resides
William ResidesCo-Founder & CEOWilliam Resides is Executive Officer and Director at BioRegenx, which develops microscopy imaging hardware and software for endothelial glycocalyx visualization alongside microvascular regenerative products for medical and wellness applications.
RL
Robert LongExecutive
GHGary Hennerberg
Gary HennerbergExecutive
HJ
Hitesh JunejaExecutive

Board

SA
Sherri AdamsBoard director
SB
Suzanne BirdBoard director
JW
Jody WalkerBoard director

Reported raises · per SEC filings

Form D private placements

$798.5K disclosed across 2 rounds · 2021–2023

▶$183KraisedApr 2023 · 5 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joseph S BirdPromoter
  • Robert DoranPromoter
  • Sherri AdamsDirector
  • Suzanne BirdDirector
  • Hans VinkExecutive Officer, Director, Promoter
  • William ResidesExecutive Officer, Director, Promoter
  • Robert LongExecutive Officer, Director, Promoter
  • Jody WalkerDirector
  • Gary HennerbergExecutive Officer, Director
  • Hitesh JunejaExecutive Officer
Offering amount
$3.6M
Amount sold
$183K
Proceeds to insiders
$150K
First sale
Jan 2023
Incorporated
Corporation, Nevada, 2021
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$615.5KraisedAug 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William ResidesExecutive Officer, Director, Promoter
  • Robert LongExecutive Officer, Director, Promoter
  • Gary Dale HennerbergExecutive Officer, Director, Promoter
  • Hans VinkExecutive Officer, Director, Promoter
  • Robert DoranExecutive Officer, Director, Promoter
  • Joseph Simmons Bird, Jr.Executive Officer, Director, Promoter
Offering amount
$3M
Amount sold
$615.5K
Proceeds to insiders
$945.9K
First sale
Jul 2021
Incorporated
Corporation, Nevada, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Regenx BiosciencesREGENXBIO is a gene therapy company developing treatments for rare and retinal diseases using its NAV Technology Platform of viral vectors, which it also licenses to other pharmaceutical and biotech companies. It operates a late-stage clinical pipeline and manufactures its investigational gene therapies at its facility in Rockville, MD.

Companies working in the same space as BioRegenx.

In the news

BioRegenx, Inc. (OTC: BRGX) Announces Major Corporate Progress, Auditor Transition, Technology Integration, and AI-Driven Strategic Vision - BioSpacebiospace.com · Dec 2025BioRegenx Announces Investor Update - Bioregenxbioregenx.com · Jul 2022

Frequently asked questions

What does BioRegenx do?
BioRegenx develops hardware and software for microscopy imaging of the endothelial glycocalyx, along with microvascular regenerative products, serving doctors, research scientists, and wellness consumers. The company combines diagnostic imaging technology with regenerative therapeutics in the medical device and wellness sector.
How much funding has BioRegenx raised?
BioRegenx has disclosed $798.5K raised across 2 rounds.
Where is BioRegenx headquartered?
BioRegenx is headquartered in Chattanooga, US.